鈴木 栄治

Last Update: 2019/06/28 08:11:08

Print

Name(Kanji/Kana/Abecedarium Latinum)
鈴木 栄治/スズキ エイジ/Suzuki, Eizi
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Associate Professor
Faculty
Org1 Job title
医学部
Concurrent Affiliation
Org1 Job title
Graduate Schools Medicine
Contact Address
Type Address(Japanese) Address(English)
Office 京都市左京区聖護院川原町54 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
Phone
Type Number
Office 075-751-3660
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本外科学会
日本乳癌学会
日本乳房オンコプラスティックサージェリー学会
日本癌治療学会
Academic Organizations Overaseas You are Affiliated to
Organization name Country
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Breast Surgeons
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 岡山大学
researchmap URL
https://researchmap.jp/7000009073
Research Topics
(Japanese)
腫瘍微小環境における免疫細胞の役割
(English)
A role of immune cells in tumor microenvironment
Fields of research (key words)
Key words(Japanese) Key words(English)
腫瘍免疫 Tumor Immunity
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Cell Rep Cell Rep Cell Rep 2018 Refereed Disclose to all
Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan PLoS One PLoS One PLoS One 2018 Refereed Disclose to all
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Breast Cancer Breast Cancer Breast Cancer 2018 Refereed Disclose to all
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety Psychooncology Psychooncology Psychooncology 2018 Refereed Disclose to all
Sugie T, Suzuki E, Yamauchi A, Yamagami K,
 Masuda N, Gondo N, Sumi E, Ikeda T, Tada H,
Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K,
 Masuda N, Gondo N, Sumi E, Ikeda T, Tada H,
Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K,
 Masuda N, Gondo N, Sumi E, Ikeda T, Tada H,
Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer The Breast The Breast The Breast 2018 Refereed Disclose to all
Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Cancer Immunol Immunother Cancer Immunol Immunother Cancer Immunol Immunother 2017 Refereed Disclose to all
Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Journal of Radiation Research Journal of Radiation Research Journal of Radiation Research 2016 Refereed Disclose to all
Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Breast Cancer Breast Cancer Breast Cancer 2016 Refereed Disclose to all
Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Biochem Biophys Res Commun Biochem Biophys Res Commun Biochem Biophys Res Commun 2015 Refereed Disclose to all
Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients BMC Cancer BMC Cancer BMC Cancer 2015 Refereed Disclose to all
Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Int J Behav Med Int J Behav Med Int J Behav Med 2015 Refereed Disclose to all
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion Cancer Immunol Res Cancer Immunol Res Cancer Immunol Res 2015 Refereed Disclose to all
Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol J Transl Med J Transl Med J Transl Med 2014 Refereed Disclose to all
Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. BMC Immunol BMC Immunol BMC Immunol 2013 Refereed Disclose to all
Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Surg Today Surg Today Surg Today 2011 Refereed Disclose to all
Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Eur J Cancer Eur J Cancer Eur J Cancer 2011 Refereed Disclose to all
Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Mol Ther Mol Ther Mol Ther 2010 Refereed Disclose to all
Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Breast Cancer Breast Cancer Breast Cancer 2009 Refereed Disclose to all
Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Oncology Oncology Oncology 2009 Refereed Disclose to all
Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer Oncol Rep Oncol Rep Oncol Rep 2009 Refereed Disclose to all
Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Cancer Biol Ther Cancer Biol Ther Cancer Biol Ther 2007 Refereed Disclose to all
Suzuki E and Toi M Suzuki E and Toi M Suzuki E and Toi M mproving the efficacy of trastuzumab in breast cancer mproving the efficacy of trastuzumab in breast cancer mproving the efficacy of trastuzumab in breast cancer Cancer Sci Cancer Sci Cancer Sci 2007 Refereed Disclose to all
Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients Clin Cancer Res Clin Cancer Res Clin Cancer Res 2007 Refereed Disclose to all
Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection Cancer Res Cancer Res Cancer Res 2007 Refereed Disclose to all
Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Cancer Research Cancer Research Cancer Research 2005 Refereed Disclose to all
Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Cancer Res Cancer Res Cancer Res 2005 Refereed Disclose to all
Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Clinical Cancer Research Clinical Cancer Research Clinical Cancer Research 2005 Refereed Disclose to all
Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Clin Cancer Res Clin Cancer Res Clin Cancer Res 2004 Refereed Disclose to all
Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation Int J Cancer Int J Cancer Int J Cancer 2004 Refereed Doctoral Thesis Disclose to all
Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil Int J Oncol Int J Oncol Int J Oncol 2004 Refereed Disclose to all

  • <<
  • >>
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Cell Symposia Cell Symposia Cell Symposia 2018 Disclose to all
HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義[Invited] HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義 [Invited] HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義 [Invited] 第26回日本乳癌学会学術総会ワークショップ 第26回日本乳癌学会学術総会ワークショップ 2018 Disclose to all
Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test AACR AACR AACR 2017 Disclose to all
Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis AACR AACR AACR 2016 Disclose to all
A role of trogocytosis of immune cells in breast tumor microenvironment[Invited] A role of trogocytosis of immune cells in breast tumor microenvironment [Invited] A role of trogocytosis of immune cells in breast tumor microenvironment [Invited] 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 2015 Disclose to all
EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients AACR AACR AACR 2015 Disclose to all
Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity AACR AACR AACR 2014 Disclose to all
Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells AACR AACR AACR 2013 Disclose to all
Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology 2012 Disclose to all
bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells AACR AACR AACR 2011 Disclose to all
Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells AACR AACR AACR 2010 Disclose to all
Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line AACR AACR AACR 2008 Disclose to all

  • <<
  • >>
Title language:
Books etc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Publisher Publisher(Japanese) Publisher(English) Publication date Language Type Disclose
Eiji Suzuki and Steven M. Albelda Eiji Suzuki and Steven M. Albelda Eiji Suzuki and Steven M. Albelda Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 2013-2015
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 (平成26年度分) 2014/04/01-2015/03/31
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 (平成27年度分) 2015/04/01-2016/03/31
基盤研究(C) Representative 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 (平成29年度分) 2017/04/01-2018/03/31
基盤研究(C) Representative 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 (平成30年度分) 2018/04/01-2019/03/31
Teaching subject(s)
Name(Japanese) Name(English) Term Department Period
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2014/04-2015/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2015/04-2016/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2016/04-2017/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2017/04-2018/03
生殖科学II Reproductive Science II 前期 医学研究科(人間健康科学系専攻) 2018/04-2019/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 医学部(人間健康科学科) 2019/04-2020/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 薬学部 2019/04-2020/03
Faculty management (title, position)
Title Period
リスクマネージャー会議 委員 2011/04/01-
病棟医長・看護師長会議 委員 2013/02/01-